Search Results
Feb 26, 2026, 09:48 ET 再鼎醫藥公佈2025年第四季度及全年財務業績和近期公司進展
肌炎： 再鼎醫藥合作夥伴argenx將於2026年第三季度公佈評估自身免疫性炎性肌病全球2/3期ALKIVIA研究的主要結果。再鼎醫藥在大中華區參與了這項研究。Povetacicept (APRIL/BAFF)IgA 腎病 (IgAN): 再鼎醫藥合作夥伴Vertex正按計劃推進，將於2026年上半年公佈全球3期RAINIER研究的中期分析。若中期分析數據支持，將於2026年上半年完成申報提交。FDA已授予該適應證突破性療法認定。原發性膜性腎病：
More news about: 再鼎醫藥
Feb 25, 2026, 10:44 ET One Identity Appoints Michael Henricks as Chief Financial and Operating Officer
leader in identity governance and administration (IGA), privileged access
More news about: One Identity
Feb 19, 2026, 05:19 ET Evolveum to Showcase AI-Driven Acceleration of IGA Application Onboarding at Gartner IAM Summit 2026
By enforcing least-privilege access, and preventing entitlement creep, IGA helps reduce the attack surface and limit how far a breach can spread.Mederly's session,"The Hidden Cost of Slow Application Onboarding in IGA", will take place on 10 March at 3:20 p.m. GMT and will focus on
More news about: Evolveum
Feb 19, 2026, 05:15 ET Evolveum to Showcase AI-Driven Acceleration of IGA Application Onboarding at Gartner IAM Summit 2026
By enforcing least-privilege access, and preventing entitlement creep, IGA helps reduce the attack surface and limit how far a breach can spread.Mederly's session,"The Hidden Cost of Slow Application Onboarding in IGA", will take place on 10 March at 3:20 p.m. GMT and will focus on
More news about: Evolveum
Feb 18, 2026, 09:00 ET Pathlock Announces Integration with ServiceNow to Embed Risk-Aware Access Governance into Enterprise Workflows
brings identity governance workflows into the ServiceNow Service Portal and Service Catalog, which becomes the "front door" for access, while Pathlock's IGA engine enforces policy, approvals, compliance, and provisioning end-to-end. The integration is available in the ServiceNow Store at:
More news about: Pathlock
Feb 17, 2026, 08:03 ET Omada Selected by Riverty Group to Support Identity Governance at Scale
identity workflows."About OmadaOmada is a global market leader in Identity Governance and Administration (IGA), offering a full-featured, cloud-native IGA solution that enables organizations to achieve compliance, reduce risk, and maximize operational efficiency. Founded in 2000,
More news about: Omada
Feb 12, 2026, 07:30 ET Soligenix Details Recent Progress and Upcoming Milestones
in the Investigator Global Assessment (IGA), the Psoriasis Activity and Severity Index (PASI), the simplified psoriasis index, the dermatology life quality index and the Skindex-29 questionnaire. One patient achieved a disease status of "Almost Clear" using the IGA, which is considered a standard clinical
More news about: SOLIGENIX, INC.
Feb 11, 2026, 01:19 ET Arctic Therapeutics Announces Enrollment of First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris
hematology, as well as pregnancy testing for women of child-bearing potential. Clinical efficacy will be assessed using the Investigator's Global Assessment (IGA) scale in combination with lesion counts at baseline and at Weeks 4, 8, and 12.The study will be conducted across three clinical sites in Denmark
More news about: Arctic Therapeutics
Feb 11, 2026, 01:14 ET Arctic Therapeutics Announces Enrollment of First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris
hematology, as well as pregnancy testing for women of child-bearing potential. Clinical efficacy will be assessed using the Investigator's Global Assessment (IGA) scale in combination with lesion counts at baseline and at Weeks 4, 8, and 12.The study will be conducted across three clinical sites in Denmark
More news about: Arctic Therapeutics
Feb 10, 2026, 08:03 ET Omada Releases State of Identity Governance 2026, Highlighting Gaps Between Identity Scale, Automation, and Executive Visibility
https://omadaidentity.com/resources/analyst-reports/state-of-iga/About OmadaOmada, a global market leader in Identity Governance and Administration (IGA), offers a full-featured,
More news about: Omada
Feb 04, 2026, 08:13 ET EMA Webinar to Explore How Organizations Can Close the Execution Gap in Identity Governance Administration (IGA)
operational complexity is the primary factor undermining IGA and Zero Trust initiativesHow access sprawl, overprovisioning, and privilege creep have emerged as today's most urgent identity riskWhat IGA modernization looks like in practice as organizations
More news about: Enterprise Management Associates
Feb 04, 2026, 01:13 ET One Identity Appoints Gihan Munasinghe as Chief Technology Officer
Trusted by more than 11,000 organizations managing over 500 million identities, One Identity is a leader in identity governance and administration (IGA), privileged access management (PAM),
More news about: One Identity
Feb 03, 2026, 16:01 ET AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
tested.The study met the key secondary endpoint of clinical response by CLASI-A 50 and by the Cutaneous Lupus Activity Investigator's Global Assessment CLA-IGA 0/1, at week 24 with both doses tested.Daxdilimab showed an acceptable safety and tolerability profile.A Phase 2 study of
More news about: Amgen
Jan 26, 2026, 10:14 ET Pathlock Appoints Key Executive Leaders to Drive Next Level of Growth
Officer, Davison will be responsible for strengthening Pathlock's global go-to-market strategy and will work closely with product and sales teams. He is an IGA industry veteran with a deep understanding of identity security and automation. Davison previously served as product leader at SailPoint, where he helped
More news about: Pathlock
Jan 20, 2026, 05:04 ET One Identity Unveils Major Upgrade to Identity Manager, Strengthening Enterprise Identity Security
top-rated IGA solution, strengthening identity governance as a critical security
More news about: One Identity
Jan 20, 2026, 03:02 ET Infosys is the Fastest Growing IT Services Brand Globally with a CAGR of 15% in Brand Value
strong collaborations, such as a decade-long partnership with ATP and brand ambassadorship programs with international tennis icons Rafael Nadal and Iga Świątek, have further strengthened Infosys' brand equity and global recognition.Recognized by Ethisphere as one of the World's Most Ethical Companies,
More news about: Infosys
Jan 20, 2026, 02:59 ET Infosys is the Fastest Growing IT Services Brand Globally with a CAGR of 15% in Brand Value
strong collaborations, such as a decade-long partnership with ATP and brand ambassadorship programs with international tennis icons Rafael Nadal and Iga Świątek, have further strengthened Infosys' brand equity and global recognition.Recognized by Ethisphere as one of the World's Most Ethical Companies,
More news about: Infosys
Jan 12, 2026, 11:15 ET Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
date:IgA Nephropathy (IgAN) Program: First dosing of BHV-1400 TRAP degrader in IgAN patients achieved early observations of both biomarker and clinical responses including: selective lowering of only the disease-causing galactose-deficient IgA1 (Gd-IgA1) while sparing off-target
More news about: Biohaven Ltd.
Dec 18, 2025, 08:45 ET PANTHERx® Rare Selected by Otsuka to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy
Nephropathy (IgAN), also known as Berger disease, is an autoimmune disease that results when clumps of IgA are deposited in the kidneys, causing inflammation and kidney damage.2,3 Normally IgA helps the body to fight infections but too much of the deposited antibodies damage glomeruli (tiny blood
More news about: PANTHERx Rare Pharmacy
Dec 17, 2025, 07:30 ET Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
in the Investigator Global Assessment (IGA), the Psoriasis Activity and Severity Index (PASI), the simplified psoriasis index, the dermatology life quality index and the Skindex-29 questionnaire. One patient achieved a disease status of "Almost Clear" using the IGA, which is considered a standard clinical
More news about: SOLIGENIX, INC.
Dec 11, 2025, 08:03 ET Omada Simplifies IGA Visibility with Access Intelligence
Denmark, Dec. 11, 2025 /PRNewswire/ -- Omada A/S ("Omada"), a global leader in Identity Governance and Administration (IGA), announced today that its platform now provides enhanced capability for Access Intelligence that unifies the company's role intelligence and role visibility
More news about: Omada
Dec 10, 2025, 11:35 ET Boehringer Ingelheim and Eli Lilly: Knowledge is Power, Especially When it Comes to Kidney Health --- It Takes 2™ is Highlighting the Importance of Complete Testing for Kidney Disease
with chronic kidney disease and type 2 diabetes. Despite experiencing symptoms at just 12 years old, it took nearly a decade for Thelma to receive her IgA Nephropathy (Nephrotic Syndrome) and chronic kidney disease diagnoses in 1993 and 1998. Today, she is a passionate advocate for all people with kidney
More news about: Boehringer Ingelheim and Eli Lilly
Dec 09, 2025, 12:00 ET Lumos Launches Industry-First Agentic User Access Reviews, Moving Towards Autonomous Identity Governance
low-risk, commonly used access from high-risk anomalies, suggesting exactly what to keep and what to remove based on real-time evidence."Traditional IGA tools just move the spreadsheet into a web app. We didn't just build a tool; we built an analyst," said Andrej Safundzic, CEO & Co-Founder of Lumos.
More news about: Lumos
Dec 09, 2025, 07:00 ET Saviynt Raises $700M at Approximately $3B Valuation in KKR-Led Round to Establish Identity Security as the Foundation for the AI Era
non-human, and AI agent identities across an organization's applications, data, and infrastructure. By converging identity management and governance (IGA), privileged access management (PAM), application access governance (AAG), identity security posture management (ISPM), and access gateways across all
More news about: Saviynt
Dec 08, 2025, 16:13 ET Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Stevens-Johnson syndrome (SJS), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and linear IgA bullous dermatosis (LABD) have been reported in association with the use of vancomycin. Cutaneous signs or symptoms reported include skin rashes, mucosal
More news about: Hikma Pharmaceuticals USA Inc.